Previous reports had shown that IDH mutation gliomas had lower lymphocyte (CD3+; PD1+) infiltration (Berghoff et al., 2017) and/or CD8+ cytotoxic T cell infiltration (Kohanbash et al., 2017). This evidence concerns the gene IDH2 and central nervous system cancer.